Found: 21
Select item for more details and to access through your institution.
Drug resistance to molecular targeted therapy and its consequences for treatment decisions in non-small-cell lung cancer.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00190
- By:
- Publication type:
- Article
Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24.
- Published in:
- 2015
- By:
- Publication type:
- journal article
miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non--Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 1, p. 52, doi. 10.1016/j.cllc.2013.08.001
- By:
- Publication type:
- Article
A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non-Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Chemoradiotherapy for locoregional recurrence of non-small-cell lung cancer after surgical resection: a retrospective analysis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first‐line platinum chemotherapy in high grade serous ovarian cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 9, p. 3045, doi. 10.1002/cam4.3831
- By:
- Publication type:
- Article
Correlation of Lactate Dehydrogenase Isoenzyme Profile With Outcome in Patients With Advanced Colorectal Cancer Treated With Chemotherapy and Bevacizumab or Ceciranib: Retrospective Analysis of the HORIZON I Study.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 1, p. 46, doi. 10.1016/j.clcc.2013.11.002
- By:
- Publication type:
- Article
Correlation of Lactate Dehydrogenase Isoenzyme Profile With Outcome in Patients With Advanced Colorectal Cancer Treated With Chemotherapy and Bevacizumab or Cediranib: Retrospective Analysis of the HORIZON I Study.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Feasibility of real time next generation sequencing of cancer genes linked to drug response: Results from a clinical trial.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 7, p. 1547, doi. 10.1002/ijc.27817
- By:
- Publication type:
- Article
Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0150567
- By:
- Publication type:
- Article
A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma.
- Published in:
- American Journal of Hematology, 1998, v. 59, n. 2, p. 156, doi. 10.1002/(SICI)1096-8652(199810)59:2<156::AID-AJH9>3.0.CO;2-X
- By:
- Publication type:
- Article
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the Lung.
- Published in:
- Oncologist, 2016, v. 21, n. 2, p. 205, doi. 10.1634/theoncologist.2015-0209
- By:
- Publication type:
- Article
Improving access to lung cancer treatment in northern Canada: the role of oral molecularly targeted agents.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Improving access to lung cancer treatment in northern Canada: the role of oral molecularly targeted agents.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic.
- Published in:
- Current Oncology, 2022, v. 29, n. 5, p. 3171, doi. 10.3390/curroncol29050258
- By:
- Publication type:
- Article